0NES.LSE

Oriola Oyj Series B

0NES.LSE, UK

Oriola Oyj provides healthcare and wellbeing products in Sweden, Finland, and internationally. The company offers over the counter (OTC) pharmaceutical and traded goods, vitamins, dietary supplements, cosmetics, skincare products, sports drinks, and wound care products. It also provides logistics, advisory, sales and marketing, and expert services for pharmaceutical companies, pharmacies, hospital pharmacies, veterinaries, as well as the grocery trade shops. In addition, the company offers pharmaceutical staffing and dose dispensing services for public and private healthcare operators, pharmacies, groceries, veterinarians, and retailers. As of December 31, 2021, it operated 319 pharmacies in Sweden, as well as operates online pharmacies. The company was formerly known as Oriola-KD Oyj and changed its name to Oriola Oyj in April 2017. Oriola Oyj is headquartered in Espoo, Finland.

https://oriola.com

Stock Price

€0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
0NES.LSE
stock
0NES.LSE

Helium One’s Southern Rukwa Phase Moves Forward as Flow-Rate Testing Nears kalkinemedia.com

Read more →
0NES.LSE
stock
0NES.LSE

Thor Energy to Sell Shares in FRAM Joint Venture to Tivan for AU$8.75 Million Investing News Network

Read more →

Showing 2 of 10

Finn Analysis

(Last Updated 2025-03-31)

Health Score

Price to Earnings Ratio (P/E)

-

Very High

0.10

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Low

1.63

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-4.07 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-0.56 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

6.67 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

6.27

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 0.00% of the total shares of Oriola Oyj Series B

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.02

Latest Release

Date

2021-12-31

EPS Actual

0.0292

EPS Estimate

—

EPS Difference

0

Surprise Percent

0%

Investing Fit Scorecard

(Last Updated 2025-03-31)

Deep Value
Strong Deep Value(7.5)
Defensive
Moderately Defensive(4)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(4.8)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(2.5)
Momentum
Moderate Momentum(4)
Net Net
Possible Net-Net(5)
Quality
Low Quality Business(3)
Value
Fair Value(6)

Income Statement

(Last Updated 2025-03-31)

Revenue

€ 0

Cost Of Revenue

€ 0

Gross Profit

€ 0

Operating Expenses

€ 0

Operating Income

€ 0

Interest Expense

€ 0

Pretax Income

€ 0

Net Income

€ 0

Income Tax Expense

€ 0

EBITDA

€ 0

Total Other Income Expense Net

€ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-03-31)

Cash

€ 0

Short Term Investments

€ 0

Receivables

€ 0

Inventories

€ 0

Total Current Assets

€ 0

Property Plant Equipment

€ 0

Total Assets

€ 0

Payables

€ 0

Short Term Debt

€ 0

Long Term Debt

€ 0

Total Liabilities

€ 0

Equity

€ 0

Trend

Cash Flow

(Last Updated 2025-03-31)

Net Income

€ 0

Depreciation

€ 0

Change In Working Capital

€ 0

Cash From Operations

€ 0

Capital Expenditures

€ 0

Cash From Investing

€ 0

Cash From Financing

€ 0

Net Change In Cash

€ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.